ACP
NXTM

Acuta Capital Partners’s NxStage Medical Inc. NXTM Stock Holding History

Acuta Capital Partners’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-53,665
Closed -$928K – 66
2015
Q1 		$928K Buy
+53,665
New +$948K 0.78% 33

Other funds holding NXTM

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
CIP
Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Acuta Capital Partners's NXTM Position: Q2 2015 in Review

Acuta Capital Partners sold out of NxStage Medical Inc. (NXTM) in Q2 2015, closing a stake of 53,665 shares — an estimated $928K sold.

Acuta Capital Partners first reported a position in NXTM in Q1 2015 and held it in 1 quarter. The position peaked at $928K in Q1 2015. 139 funds tracked by Wall St. Rank hold NXTM as of Q2 2015.

  • Acuta Capital Partners reported no remaining NxStage Medical Inc. position as of Q2 2015 after selling out during the quarter.
  • Acuta Capital Partners sold 53,665 NxStage Medical Inc. shares in Q2 2015, an estimated $928K.
  • Acuta Capital Partners first reported a position in NxStage Medical Inc. in Q1 2015 and held it in 1 quarter.
  • Acuta Capital Partners's NxStage Medical Inc. position peaked at $928K in Q1 2015.
  • 139 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q2 2015.

Based on Acuta Capital Partners's 13F filing for Q2 2015, filed 14 Aug 2015.